Evidence map›Paper›PMID 36430472›Full record

ArticleInternational journal of molecular sciences2022

Identification of Epigenetic Interactions between MicroRNA-30c-5p and DNA Methyltransferases in Neuropathic Pain.

Raquel Francés, Jorge Mata-Garrido, Roberto de la Fuente, María Carcelén, Miguel Lafarga, María Teresa Berciano, Raquel García, María A Hurlé, Mónica Tramullas

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. The Role of Methylation Modification in Neural Injury and Repair.International journal of molecular sciences · 2025
    Review
  2. Review
  3. The simultaneous activation of μ- and δ-opioid receptors by (-)-2Current research in pharmacology and drug discovery · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Pathology of pain and its implications for therapeutic interventions.Signal transduction and targeted therapy · 2024
    Review
  8. Review
  9. Role of Recognition MicroRNAs inPathogens (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Raquel FrancésDepartamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.ORCID 0000-0003-1428-4852
Jorge Mata-GarridoInstituto de Investigación Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain.
Roberto de la FuenteServicio de Anestesiología, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
María CarcelénDepartamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.
Miguel LafargaInstituto de Investigación Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain.ORCID 0000-0003-3402-1152
María Teresa BercianoInstituto de Investigación Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain.ORCID 0000-0002-8225-6995
Raquel GarcíaDepartamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.
María A HurléDepartamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.ORCID 0000-0002-7710-1358
Mónica TramullasDepartamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.ORCID 0000-0002-2447-8928
Universidad de Cantabria · ESMarqués de Valdecilla University Hospital · ES

Funding

Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL) NVAL17/ 23MCIN/AEI/ 10.13039/501100011033 PID2019-104398RB-I00MCIN/AEI/ 10.13039/501100011033 and by "ERDF A way of making Europe"; SAF2016-77732-R
6 · The paper itself

Abstract

Neuropathic pain is a prevalent and severe chronic syndrome, often refractory to treatment, whose development and maintenance may involve epigenetic mechanisms. We previously demonstrated a causal relationship between miR-30c-5p upregulation in nociception-related neural structures and neuropathic pain in rats subjected to sciatic nerve injury. Furthermore, a short course of an miR-30c-5p inhibitor administered into the cisterna magna exerts long-lasting antiallodynic effects via a TGF-β1-mediated mechanism. Herein, we show that miR-30c-5p inhibition leads to global DNA hyper-methylation of neurons in the lumbar dorsal root ganglia and spinal dorsal horn in rats subjected to sciatic nerve injury. Specifically, the inhibition of miR-30-5p significantly increased the expression of the novo DNA methyltransferases DNMT3a and DNMT3b in those structures. Furthermore, we identified the mechanism and found that miR-30c-5p targets the mRNAs of DNMT3a and DNMT3b. Quantitative methylation analysis revealed that the promoter region of the antiallodynic cytokine TGF-β1 was hypomethylated in the spinal dorsal horn of nerve-injured rats treated with the miR-30c-5p inhibitor, while the promoter of Nfyc, the host gene of miR-30c-5p, was hypermethylated. These results are consistent with long-term protection against neuropathic pain development after nerve injury. Altogether, our results highlight the key role of miR-30c-5p in the epigenetic mechanisms' underlying neuropathic pain and provide the basis for miR-30c-5p as a therapeutic target.

Indexed as

MicroRNAsNeuralgiaPeripheral Nerve InjuriesSciatic NeuropathyAnimalsDNADNA Modification MethylasesEpigenesis, GeneticRatsRats, Sprague-DawleyTransforming Growth Factor beta1DNADNA Modification MethylasesMicroRNAsMIRN30 microRNA, ratTransforming Growth Factor beta1DNA methylationDNMTsepigeneticmiR-30c-5pneuropathic painTGF-β1

Identifiers

PMID36430472
PMCPMC9694031
OpenAlexW4308972962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.